• 28 March, 2020

Yolse’s Statement on Covid-19.

  • 4 June, 2019

More than 60 health organisations are calling for rapid reform of the Harare Protocol of the African Regional Intellectual Property Organization (ARIPO) in order to protect public health across its. 

  • Geneva, 28 May, 2019

Member States adopt the resolution on ‘Improving the transparency of markets for medicines, vaccines, and other health products’ at WHA.

  • Geneva, May 16, 2019

Civil Society Organisations (CSOs) are writing to request the updating of WHO Guideline on the Evaluation of Similar Biotherapeutic Products (SBPs) (SBP Guideline) as mandated by the World Health Assembly (WHA) resolution.

  • Geneva, 9 May, 2019

Civil Society Open Letter to World Health Assembly Delegates on Transparency Resolution Negotiations.

  • Geneva, 16 April, 2019

Statement from 64 civil society organisations and coalitions ahead of the second meeting of the Fair Pricing Forum, hosted by the World Health Organization and South African government April 11-13th in Johannesburg.

  • Geneva, 2 April, 2019

92 civil society organizations (CSOs), individuals and others working to improve innovation, access to medicines and healthcare around the world letter to the President of the 73rd session of the UN General Assembly, stress the need for a high-level UN response to help address the crisis in innovation and access to safe, effective, quality and affordable medicines, diagnostics and vaccines.

  • Geneva, 6 March, 2019

83 civil society organisations and 20 individuals are urging all WHO Member States to support actions to improve the transparency of medical R&D, prices, patents and clinical trials.

  • Geneva, August 7, 2018.

Letter to Dr. Tedros on the WHO Roadmap on Access to Medicines and Vaccines 2019-2023

  • Geneva, August 3, 2018

16 groups sent an open letter to WHO Director-General, Dr Tedros Adhanom Ghebreyesus expressing views on the proposed WHO Roadmap on Access to Medicines and Vaccines 2019-2023.

  • Geneva, July 31, 2018.

Yolse’s Statement Following South Africa’s Decision to Break The Silence on The UN Political Declaration on TB.

  • Geneva, July 4, 2018

242 civil society, advocacy organisations, academics and activists concerned with access to medicines, human rights and health around the world letter on High prices that limit access to affordable medicines, diagnostics and vaccines must be urgently addressed in the third HLM on NCDs.

  • Geneva, June 8, 2018.

The Francophone civil society’s response to the declaration submitted for signature to the Ministers of Health of French-speaking African countries at the international conference on access to quality medicines and other medical products on May 22, 2018, initiated in Geneva by UNAIDS and OIF.

  • Carouge, May 30, 2017.

Yolse’s statement on the election of Dr. Tedros Adhanom Ghebreyesus as head of the World Health Organization (WHO).

  • Carouge, December 7, 2016.

Yolse’s statement to the UNAIDS Program Coordinating Board (PCB).

  • Carouge, November 10, 2016.

Yolse’s statement following the publication of the Lancet Commission Report on Essential Medicines and Universal Health Coverage.

  • Carouge, September 16, 2016.

Yolse’s statement to the publication of the final report of the UN Secretary-General’s High-Level Group

  •  Carouge, May 25, 2016.

Yolse supported by UNAIDS issued a statement inviting Least Developed Countries (LDCs) members of OAPI to explicitly send a letter to the Director of this institution notifying their willingness to implement immediately the 6 November 2015 decision of the Council of TRIPS.

  • Carouge, December 7, 2015.

UNAIDS and UNDP’s joint letter inviting the Director of OAPI to take into consideration the recommendations of the 23 November 2015 workshop on integrating the transitional period for LDCs into the current Bangui Agreement that is being reviewed.